These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 7726206

  • 1. Is cholinergic sensitivity a genetic marker for the affective disorders?
    Janowsky DS, Overstreet DH, Nurnberger JI.
    Am J Med Genet; 1994 Dec 15; 54(4):335-44. PubMed ID: 7726206
    [Abstract] [Full Text] [Related]

  • 2. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C, Bunck M, Glasl L, Nussbaumer M, Palme R, Stein H, Wolferstätter M, Zeh R, Zimbelmann M, Holsboer F, Landgraf R.
    Psychoneuroendocrinology; 2008 Jul 15; 33(6):839-62. PubMed ID: 18502051
    [Abstract] [Full Text] [Related]

  • 3. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 15; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 4. [Cholinergic hypothesis of depression].
    Leboyer M, Plaisant O.
    Encephale; 1985 Oct 15; 11(6):229-34. PubMed ID: 3913597
    [Abstract] [Full Text] [Related]

  • 5. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
    Dilsaver SC.
    J Clin Psychopharmacol; 1986 Apr 15; 6(2):65-74. PubMed ID: 3517080
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands.
    Ising M, Lauer CJ, Holsboer F, Modell S.
    J Psychiatr Res; 2005 Jan 15; 39(1):21-8. PubMed ID: 15504420
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ, Nemeroff CB.
    Depress Anxiety; 2000 Jan 15; 12 Suppl 1():2-19. PubMed ID: 11098410
    [Abstract] [Full Text] [Related]

  • 10. Evidence of an association between the vasopressin V1b receptor gene (AVPR1B) and childhood-onset mood disorders.
    Dempster EL, Burcescu I, Wigg K, Kiss E, Baji I, Gadoros J, Tamás Z, Kennedy JL, Vetró A, Kovacs M, Barr CL.
    Arch Gen Psychiatry; 2007 Oct 15; 64(10):1189-95. PubMed ID: 17909131
    [Abstract] [Full Text] [Related]

  • 11. A view on noradrenergic, hypothalamic-pituitary-adrenal axis and extrahypothalamic corticotrophin-releasing factor function in anxiety and affective disorders: the reduced growth hormone response to clonidine.
    Coplan JD, Pine DS, Papp LA, Gorman JM.
    Psychopharmacol Bull; 1997 Oct 15; 33(2):193-204. PubMed ID: 9230631
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The involvement of nitric oxide and prostaglandins in the cholinergic stimulation of hypothalamie-pituitary-adrenal response during crowding stress.
    Bugajski AJ, Gadek-Michalska A, Bugajski J.
    J Physiol Pharmacol; 2006 Sep 15; 57(3):463-77. PubMed ID: 17033098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.